DR.REDDY'S Laboratories LIMITED

Form 483 issued June 21, 2019 · Visakhapatnam, India

Inspection
Jun 13 – Jun 21, 2019
Observations
2
Pages
3
FEI number
3006549835

In short: On June 21, 2019, FDA issued a Form 483 with 2 observations to DR.REDDY'S Laboratories LIMITED in Visakhapatnam, India (FEI 3006549835) after an inspection that ran Jun 13 – Jun 21, 2019. The investigators were Farhana Khan and Monica C. Burgos Garcia. Most observations concern laboratory controls and design controls; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Laboratory controls and design controls account for 2 of 2 observations.

Laboratory controls1
Design controls1

Most cited: 21 CFR 211.160 (1×) · 820.30 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Acceptance criteria were not established prior to the…

  2. 02

    The device design was not correctly…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at DR.REDDY'S Laboratories LIMITED?

FDA listed 2 observations on this Form 483, mostly about laboratory controls and design controls. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected DR.REDDY'S Laboratories LIMITED?

Farhana Khan and Monica C. Burgos Garcia are named on this Form 483, for the inspection of Jun 13 – Jun 21, 2019. Each investigator has a profile showing what they cite most.

When was DR.REDDY'S Laboratories LIMITED inspected by FDA?

The inspection ran Jun 13 – Jun 21, 2019, and the Form 483 is dated June 21, 2019.

How do I get the full Form 483 for DR.REDDY'S Laboratories LIMITED?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free